Physician profile
Hope Snively
NPI 1881608230
$3,811.33
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $313 · 2021: $399 · 2022: $816 · 2023: $731 · 2024: $1,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,812 · Entertainment: $46.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.19 |
| Entertainment | $46.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,189.65 | 2022-2024 | Infuse, Xiidra |
| Alcon Vision LLC | $864.47 | 2019-2024 | Total30, Precision 1, Precision 7 |
| Johnson & Johnson Vision Care, INC. | $426.07 | 2019-2024 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $407.29 | 2019-2021 | |
| Coopervision INC. | $261.25 | 2019-2024 | Clariti Contact Lens, Myday Contact Lens |
| Abbvie INC. | $119.78 | 2022-2024 | |
| Carl Zeiss Meditec, INC. | $112.84 | 2019 | |
| Abb Con-Cise Optical Group LLC | $77.25 | 2020-2024 | Contact Lens, Spectacle Lenses |
| Oasis Medical, INC. | $62.27 | 2019-2024 | Oasis Tears |
| Allergan, INC. | $57.92 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $51.34 | 2019-2024 | |
| Optos, INC. | $46.39 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $37.85 | 2022-2024 | Tyrvaya |
| Rxsight INC | $36.57 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Sight Sciences, INC. | $20.80 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $14.52 | 2023 | Tearlab Osmolarity System |
| Kala Pharmaceuticals, INC. | $13.25 | 2021 | |
| Plexus Optix, INC. | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Snively listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.